[fusion_builder_container hundred_percent= »no » equal_height_columns= »no » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » background_position= »center center » background_repeat= »no-repeat » fade= »no » background_parallax= »none » enable_mobile= »no » parallax_speed= »0.3″ video_aspect_ratio= »16:9″ video_loop= »yes » video_mute= »yes » overlay_opacity= »0.5″ border_style= »solid » padding_top= »20px » padding_bottom= »20px »][fusion_builder_row][fusion_builder_column type= »1_1″ spacing= » » center_content= »no » hover_type= »none » link= » » min_height= » » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » class= » » id= » » background_color= » » background_image= » » background_position= »left top » undefined= » » background_repeat= »no-repeat » border_size= »0″ border_color= » » border_style= »solid » border_position= »all » padding= » » margin_top= » » margin_bottom= »0px » animation_type= » » animation_direction= »left » animation_speed= »0.3″ animation_offset= » » last= »no »][fusion_text]
Marcy l’Etoile, le 23 septembre 2021
[/fusion_text][/fusion_builder_column][fusion_builder_column type= »1_2″ spacing= » » center_content= »no » hover_type= »none » link= » » min_height= » » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » class= » » id= » » background_color= » » background_image= » » background_position= »left top » background_repeat= »no-repeat » border_size= »0″ border_color= » » border_style= »solid » border_position= »all » padding= » » dimension_margin= »undefined » animation_type= » » animation_direction= »left » animation_speed= »0.3″ animation_offset= » » last= »no »][fusion_imageframe image_id= »140705″ style_type= »none » hover_type= »zoomin » borderradius= »10px » align= »center » lightbox= »no » linktarget= »_self » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » animation_direction= »left » animation_speed= »0.3″]https://www.afssi.fr/wp-content/uploads/2021/10/20211001-Cynbiose-hawkcell-image-2-525×350.jpg[/fusion_imageframe][/fusion_builder_column][fusion_builder_column type= »1_2″ spacing= » » center_content= »no » hover_type= »none » link= » » min_height= » » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » class= » » id= » » background_color= » » background_image= » » background_position= »left top » undefined= » » background_repeat= »no-repeat » border_size= »0″ border_color= » » border_style= »solid » border_position= »all » padding= »0px 0px 0px 0px » margin_top= »-20px » margin_bottom= » » animation_type= » » animation_direction= »left » animation_speed= »0.3″ animation_offset= » » last= »no »][fusion_text]
Cynbiose SAS, a preclinical CRO, and HawkCell, a young innovative company specialized in MRI (Magnetic Resonance Imaging) for small and large animals, join forces to offer a global R&D and commercial service for preclinical studies focused on the non-human primate model.
[/fusion_text][/fusion_builder_column][fusion_builder_column type= »1_1″ layout= »1_1″ spacing= » » center_content= »no » hover_type= »none » link= » » min_height= » » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » class= » » id= » » background_color= » » background_image= » » background_position= »left top » background_repeat= »no-repeat » border_size= »0″ border_color= » » border_style= »solid » border_position= »all » padding= » » dimension_margin= » » animation_type= » » animation_direction= »left » animation_speed= »0.3″ animation_offset= » » last= »no »][fusion_text]
The partnership between Cynbiose and HawkCell will provide both a collaborative R&D offer with biopharmaceutical companies for the development and characterization of physiopathological models. It will also strengthen imaging capabilities for preclinical studies in the translational NHP model.
[/fusion_text][fusion_separator style_type= »none » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » bottom_margin= »30px » alignment= »center » /][fusion_title hide_on_mobile= »small-visibility,medium-visibility,large-visibility » size= »2″ content_align= »center » style_type= »single solid »]
Lire le communiqué (en)
[/fusion_title][fusion_text]
[pdf-embedder url= »https://www.afssi.fr/wp-content/uploads/2021/10/Press-release-Cynbiose-HawkCell-partnership-in-MRI-Sept-2021.pdf » title= »Press release – Cynbiose HawkCell partnership in MRI – Sept 2021″]
[/fusion_text][fusion_button link= »https://www.afssi.fr/wp-content/uploads/2021/10/Press-release-Cynbiose-HawkCell-partnership-in-MRI-Sept-2021.pdf » target= »_blank » alignment= »center » hide_on_mobile= »small-visibility,medium-visibility,large-visibility » color= »default » stretch= »default » icon_position= »left » icon_divider= »no » animation_direction= »left » animation_speed= »0.3″]Télécharger[/fusion_button][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]
